Supply of Medicine and Medical / Surgical equipments : Anti Rabies serum (equine) Injection 1,000\nIU in 5ml Ampoule.\nRabies Antiserum BP 1000 IU/5mL OR\nAnti Rabies Serum USP 1000 IU/5mL\nEach 5mL ampoule to contain 1000 IU of\nRabies Antiserum BP or Anti Rabies Serum\nUSP\nNote 1:\n1. This injection should be stable for 24 months\nwhen stored within a temperature range of 2'C-\n8'C. Do not freeze.\n2. Each consignment should have a minimum\nremaining shelf life of 75% at the time of\nreceiving the consignment at MSD.\n3. Cold chain monitors should be included for\neach carton and cold chain should be\nmaintained according to the manufacturer's\ninstructions during storage, transport and\ndelivery of item.\n4. Each vial should be labelled accordingly.\nNote\nThe following documents should be submitted\npre- shipment for each lot of serum dispatched.\n1. Summary protocols for production and\nquality testing (Including protocols for\nimmunization, initial pool, final bulk and finished\nproduct ) based on WHO model summary\nprotocols.\n2. Lot release certificate from National Control\nLaboratory of manufacturing country for that\nparticular batch.\n3. Certificate of analysis of finished product.\n4. Certificate of analysis of diluents, if\napplicable.\n5. The package information leaflet.\nPacking : One vial etc .

STATE PHARMACEUTICALS CORPORATION OF SRI LANKA Sri Lanka has Released a tender for Supply of Medicine and Medical / Surgical equipments : Anti Rabies serum (equine) Injection 1,000\nIU in 5ml Ampoule.\nRabies Antiserum BP 1000 IU/5mL OR\nAnti Rabies Serum USP 1000 IU/5mL\nEach 5mL ampoule to contain 1000 IU of\nRabies Antiserum BP or Anti Rabies Serum\nUSP\nNote 1:\n1. This injection should be stable for 24 months\nwhen stored within a temperature range of 2'C-\n8'C. Do not freeze.\n2. Each consignment should have a minimum\nremaining shelf life of 75% at the time of\nreceiving the consignment at MSD.\n3. Cold chain monitors should be included for\neach carton and cold chain should be\nmaintained according to the manufacturer's\ninstructions during storage, transport and\ndelivery of item.\n4. Each vial should be labelled accordingly.\nNote\nThe following documents should be submitted\npre- shipment for each lot of serum dispatched.\n1. Summary protocols for production and\nquality testing (Including protocols for\nimmunization, initial pool, final bulk and finished\nproduct ) based on WHO model summary\nprotocols.\n2. Lot release certificate from National Control\nLaboratory of manufacturing country for that\nparticular batch.\n3. Certificate of analysis of finished product.\n4. Certificate of analysis of diluents, if\napplicable.\n5. The package information leaflet.\nPacking : One vial etc . in Pharmaceuticals. The tender was released on Mar 20, 2025.

Country - Sri Lanka

Summary - Supply of Medicine and Medical / Surgical equipments : Anti Rabies serum (equine) Injection 1,000\nIU in 5ml Ampoule.\nRabies Antiserum BP 1000 IU/5mL OR\nAnti Rabies Serum USP 1000 IU/5mL\nEach 5mL ampoule to contain 1000 IU of\nRabies Antiserum BP or Anti Rabies Serum\nUSP\nNote 1:\n1. This injection should be stable for 24 months\nwhen stored within a temperature range of 2'C-\n8'C. Do not freeze.\n2. Each consignment should have a minimum\nremaining shelf life of 75% at the time of\nreceiving the consignment at MSD.\n3. Cold chain monitors should be included for\neach carton and cold chain should be\nmaintained according to the manufacturer's\ninstructions during storage, transport and\ndelivery of item.\n4. Each vial should be labelled accordingly.\nNote\nThe following documents should be submitted\npre- shipment for each lot of serum dispatched.\n1. Summary protocols for production and\nquality testing (Including protocols for\nimmunization, initial pool, final bulk and finished\nproduct ) based on WHO model summary\nprotocols.\n2. Lot release certificate from National Control\nLaboratory of manufacturing country for that\nparticular batch.\n3. Certificate of analysis of finished product.\n4. Certificate of analysis of diluents, if\napplicable.\n5. The package information leaflet.\nPacking : One vial etc .

Deadline - Apr 30, 2025

MT reference number - 105339263

Product classification - Pharmaceutical products